Comerica Incorporated (NYSE: CMA) has a higher price-to-earnings ratio of 5.26x compared to its average ratio,, and the 36-month beta value for CMA is at 1.25. Analysts have varying views on the stock, with 13 analysts rating it as a “buy,” 3 rating it as “overweight,” 8 as “hold,” and 2 as “sell.”
The average price suggested by analysts for CMA is $79.79, which is $35.72 above the current market price. The public float for CMA is 130.17M, and currently, shorts hold a 2.44% of that float. The average trading volume for CMA on March 21, 2023 was 2.55M shares.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it’s about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there’s never been a better time to invest in this burgeoning industry. That’s why we’ve compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
CMA) stock’s latest price update
Comerica Incorporated (NYSE: CMA)’s stock price has increased by 2.25 compared to its previous closing price of 43.59. Despite this, the company has seen a gain of 4.77% in its stock price over the last five trading days.
CMA’s Market Performance
Comerica Incorporated (CMA) has experienced a 4.77% rise in stock performance for the past week, with a -39.82% drop in the past month, and a -30.03% drop in the past quarter. The volatility ratio for the week is 15.42%, and the volatility levels for the past 30 days are at 9.65% for CMA. The simple moving average for the last 20 days is -28.56% for CMA stock, with a simple moving average of -38.80% for the last 200 days.
Analysts’ Opinion of CMA
Many brokerage firms have already submitted their reports for CMA stocks, with UBS repeating the rating for CMA by listing it as a “Buy.” The predicted price for CMA in the upcoming period, according to UBS is $68 based on the research report published on March 15th of the current year 2023.
Piper Sandler gave a rating of “Neutral” to CMA, setting the target price at $82 in the report published on February 15th of the current year.
CMA Trading at -34.53% from the 50-Day Moving Average
After a stumble in the market that brought CMA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -54.30% of loss for the given period.
Volatility was left at 9.65%, however, over the last 30 days, the volatility rate increased by 15.42%, as shares sank -38.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -32.53% lower at present.
During the last 5 trading sessions, CMA rose by +4.77%, which changed the moving average for the period of 200-days by -44.82% in comparison to the 20-day moving average, which settled at $60.97. In addition, Comerica Incorporated saw -33.33% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at CMA starting from McKinney Cassandra M., who sale 362 shares at the price of $72.70 back on Jan 31. After this action, McKinney Cassandra M. now owns 6,250 shares of Comerica Incorporated, valued at $26,316 using the latest closing price.
McKinney Cassandra M., the EVP of Comerica Incorporated, sale 3,262 shares at $72.76 during a trade that took place back on Jan 27, which means that McKinney Cassandra M. is holding 6,825 shares at $237,358 based on the most recent closing price.
Stock Fundamentals for CMA
Current profitability levels for the company are sitting at:
- +41.12 for the present operating margin
The net margin for Comerica Incorporated stands at +31.53. Equity return is now at value 20.30, with 1.30 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.16.
In conclusion, Comerica Incorporated (CMA) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.